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Introduction
============

Assessing the comparative effectiveness of many or all available interventions for a clinical indication is challenging.[@ref1] Direct evidence from head to head trials is often lacking.[@ref2] [@ref3] [@ref4] [@ref5] Indirect comparison between two interventions can still be estimated from the results of randomised controlled trials, without jeopardising the randomised comparisons within each trial, if each intervention is compared with an identical common comparator.[@ref6] [@ref7] When both direct and indirect comparisons are available, the two sources of information can be combined by using network meta-analyses---also known as multiple treatments meta-analyses or mixed treatment comparison meta-analyses.[@ref8] [@ref9] These methods allow for estimating all possible pairwise comparisons between interventions and placing them in rank order.

In the past few years, network meta-analyses have been increasingly adopted for comparing healthcare interventions.[@ref10] [@ref11] [@ref12] Network meta-analyses are attractive for clinical researchers because they seem to respond to their main concern: determining the best available treatment. Moreover, national agencies for health technology assessment and drug regulators increasingly use such methods.[@ref13] [@ref14] [@ref15] [@ref16]

Several reviews previously evaluated how indirect comparisons have been conducted and reported.[@ref7] [@ref10] [@ref11] [@ref12] [@ref17] [@ref18] These reviews focused on checking validity assumptions (based on homogeneity, similarity, and consistency) and did not assess the key components of the systematic review process. Network meta-analyses are primarily meta-analyses, and should therefore be performed according to the explicit and rigorous methods used in systematic reviews and meta-analyses to minimise bias.[@ref19] We performed a methodological systematic review of published reports of network meta-analyses to examine how they were reported and conducted. In particular, we assessed whether the reports adequately featured the key methodological components of the systematic review process.

Methods
=======

Search strategy
---------------

We systematically searched for all published network meta-analyses in the following databases from their dates of inception: Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Medline, and Embase. Search equations were developed for each database and were based partly on search terms used by Song and colleagues[@ref12] and Salanti and colleagues[@ref20] (web table 1). The equations were based on specific free text words pertaining to network meta-analyses or overviews of reviews. The date of the last search was 12 July 2012. We also screened the references of methodology papers and reviews[@ref11] [@ref12] [@ref13] [@ref14] [@ref15] [@ref16] [@ref17] [@ref21] and searched for papers citing landmark statistical articles through the Web of Science or SCOPUS database.[@ref6] [@ref8] [@ref22] [@ref23] [@ref24]

Eligibility criteria
--------------------

All reports of network meta-analyses comparing the clinical efficacy of three or more interventions based on randomised controlled trials were eligible. We excluded reports of adjusted meta-analyses involving indirect comparisons (that is, an open loop network of three interventions)[@ref10] [@ref13] [@ref17] as well as publications of methodology, editorial style reviews or reports, cost effectiveness reviews, reviews based on individual patient data, and reviews not involving human participants. We also excluded reviews not published in English, French, German, Spanish, and Italian.

Selection of relevant reports of network meta-analyses
------------------------------------------------------

Two reviewers (AB, LT) independently selected potentially relevant reports of network meta-analyses on the basis of the title and abstract and, if needed, the full text according to prespecified eligibility criteria. Disagreements were discussed to reach consensus.

Data extraction
---------------

A standardised form was used to collect all data from the original reports of network meta-analyses and supplementary appendices when available. We collected all data for epidemiological and descriptive characteristics and those pertaining to the key methodological components of the systematic review process. Two reviewers (AB, RS) independently extracted all data from a random sample of 20% of reports. From all reports, two reviewers (AB, RS) independently extracted data for items that involved subjective interpretation. The corresponding items were questions referring to participants, interventions, comparisons, and outcomes; the type of comparator; how reporting bias was assessed; the publication status of selected randomised controlled trials; and whether statistical assumptions (homogeneity, similarity, and consistency) were mentioned. Disagreements were resolved by discussion.

General characteristics
-----------------------

The following general characteristics were collected: journal name, year of publication, country of corresponding author, medical area, funding source, and type of interventions included in the network. We categorised journal types into general or specialty; we also identified journals with high impact factors (that is, the 10 journals with the highest impact factor for each medical subject category of the *Journal Citation Reports* 2011). Regarding network typology, we collected the number of interventions, the number of comparisons conducted by at least one randomised controlled trial (that is, direct comparisons), and the number of randomised controlled trials included in the network.

Reporting of key methodological components of the systematic review process
---------------------------------------------------------------------------

According to PRISMA[@ref25] and AMSTAR[@ref26] guidelines, we assessed whether key methodological components were reported or not. In the introduction and methods sections of each report, these factors included:

-   Questions referring to participants, interventions, comparisons, and outcomes

-   Existence of a review protocol

-   Primary outcome explicitly specified in the article or abstract, in the primary study objectives, or as the only outcome reported in the article[@ref27]

-   Information sources including databases searched, electronic search strategy, date of last search and period covered by the search of each database, any other sources (conference abstracts, unpublished studies, textbooks, specialty registers (for example, the US Food and Drug Administration), contact with study authors, reviewing the references in the studies found or any relevant systematic reviews), ongoing studies searched, and any or no restrictions related to language or publication status (that is, published studies or any other sources or ongoing studies)

-   Methods for study selection and data extraction

-   Methods used for assessing risk of bias of individual studies, such as use of any scales, checklists, or domain based evaluation recommended by the Cochrane Collaboration, with separate critical assessments for different domains (that is, allocation concealment, generation of sequence allocation, blinding, incomplete outcome data, or selective reporting)

-   Methods to incorporate assessment of risk of bias of individual studies in the analysis or conclusion of review (that is, subgroup analysis, inclusion criteria, sensitivity analysis, or the grading recommendations assessment development and evaluation (GRADE))[@ref28]

-   Methods to assess publication or reporting bias (statistical or graphical evaluation).

Regarding the search strategy, we distinguished between a "de novo" search (a new comprehensive literature search) and a mixed search strategy (an initial search for systematic reviews complemented by an updated search of trials not covered by the search period of these systematic reviews).

In the results section, we assessed whether reports included the following components:

-   Study selection, including the number of studies screened, assessed for eligibility, and included in the review; with reasons for exclusions at each stage (for example, a PRISMA flowchart) and the list of studies included and excluded

-   Study characteristics, including a description of the trial network with the number of interventions and number of comparisons conducted by at least one randomised controlled trial (that is, direct comparisons), characteristics of patients (for example, age, sex, disease status, severity), duration of follow-up of patients and duration of interventions, description of interventions, number of study groups and patients, and funding sources

-   Risk of bias within studies

-   Risk of bias across studies (publication bias).

Finally, we assessed whether the discussion section included:

-   A limitation regarding reporting bias

-   Whether the authors mentioned or discussed the assumptions required in network meta-analyses (based on homogeneity, similarity, consistency, and exchangeability)

-   Whether authors mentioned a conflict of interest.

Conduct quality when the reporting was adequate
-----------------------------------------------

When items were adequately reported, we subsequently assessed whether the conduct quality was adequate. We considered the following items as inadequate conduct: electronic search of only one bibliographic database, restricting study selection to published reports, lack of independent duplicate study selection, and lack of independent duplicate data extraction.

Composite outcome assessing inadequate reporting or inadequate conduct quality
------------------------------------------------------------------------------

To summarise data, we built two composite outcomes assessing inadequate reporting or inadequate conduct quality (when the reporting was adequate). The first composite outcome was based on guidelines from Li and colleagues.[@ref29] Inadequate reporting or conduct quality was considered as one of the following:

-   The authors did not report a literature search, they reported an electronic search of only one bibliographic database, or they did not supplement their investigation by searching for any other sources

-   The authors did not report an assessment of risk of bias of individual studies.

The second composite outcome was defined as an all or none approach, based on seven methodological items identified as mandatory according to the methodological expectations of Cochrane intervention reviews.[@ref30] Conduct or reporting quality was considered inadequate if:

-   The authors did not report questions referring to participants, interventions, comparisons, and outcomes

-   The authors did not report eligibility criteria

-   The authors did not report a literature search; they reported an electronic search of only one bibliographic database; or they did not supplement their investigation by searching for references in studies found, any relevant systematic reviews, or ongoing studies (for example, [clinicaltrials.gov](clinicaltrials.gov) or the World Health Organization International Clinical Trials Registry Platform)

-   The authors did not report the methods of study selection and the data extraction process, or they reported inadequate methods

-   The authors did not report the results of the selection of primary studies

-   The authors did not provide a description of the primary studies

-   The authors did not report an assessment of the risk of bias of individual studies.

Statistical analysis
--------------------

Quantitative data were summarised by medians and interquartile ranges, and categorical data summarised by numbers and percentages. We compared general characteristics and reporting of key items for network meta-analyses with results published in general and specialty journals and with public and private funding sources. All or none measurements were analysed by χ^2^ tests for categorical data. All tests were two sided, and P\<0.05 was considered significant. Statistical analyses involved use of SAS version 9.3 (SAS Institute).

Results
=======

General characteristics
-----------------------

Our search identified 1226 citations, including 333 duplicate citations. Among the 893 potentially relevant publications, 118 were eligible reports of network meta-analyses. Three additional network meta-analyses were identified from methodological articles, resulting in 121 eligible reports of network meta-analyses (figs 1[](#fig1){ref-type="fig"} and 2[](#fig2){ref-type="fig"}; web table 2 shows the main characteristics of the network meta-analyses^w1-w121^).

![**Fig 1** Flowchart of selection of network meta-analyses. CDSR=Cochrane Database of Systematic Reviews; DARE= Database of Abstracts of Reviews of Effects; NMA=network meta-analysis; RCT= randomised controlled trial](bafa011247.f1_default){#fig1}

![**Fig 2** Number of reports of network meta-analyses published per year. \*We estimated the number of reports published from July to December 2012 on the basis of the number of published network meta-analyses from the six previous months. Between January and June 2012, 27 reports were published (dark region); therefore, we estimated 27 reports from July to December 2012 (light region)](bafa011247.f2_default){#fig2}

Reports of network meta-analyses were published in 75 different journals, with 55 reports (45%) published in general journals, 66 (55%) in specialty journals, and 56 (46%) in journals with a high impact factor (table 1[](#tbl1){ref-type="table"}; web table 3). The network meta-analyses covered a wide range of medical areas, and 100 (83%) described the assessment of pharmacological interventions. The median number of interventions assessed per network meta-analysis was seven (interquartile range 5-9), and the median number of randomised controlled trials included per network meta-analysis was 22 (15-40).

###### 

 Epidemiological and descriptive characteristics of 121 reports of network meta-analyses

  Item and subcategory                                                                                   No (%) of reports
  ------------------------------------------------------------------------------------------------------ -------------------
  **Journal type**                                                                                       
  General journal                                                                                        55 (45)
   With high impact factor                                                                               29 (53)
  Specialty journal                                                                                      66 (55)
   With high impact factor                                                                               27 (41)
  **Location of corresponding author**                                                                   
  Europe                                                                                                 69 (57)
  North America                                                                                          38 (31)
  Asia                                                                                                   8 (7)
  South America                                                                                          3 (2)
  Oceania                                                                                                3 (2)
  **Funding source**                                                                                     
  Private                                                                                                41 (34)
  Public                                                                                                 40 (33)
  None                                                                                                   15 (12)
  Both private and public                                                                                7 (6)
  Unclear                                                                                                18 (15)
  **Medical area**                                                                                       
  Cardiology                                                                                             27 (22)
  Rheumatology                                                                                           16 (13)
  Endocrinology                                                                                          12 (10)
  Oncology                                                                                               10 (8)
  Infectious disease                                                                                     9 (7)
  Psychiatry/psychology                                                                                  8 (7)
  Neurology                                                                                              8 (7)
  Respiratology                                                                                          6 (5)
  Ophthalmology                                                                                          5 (4)
  Surgery                                                                                                5 (4)
  Other (≤3 reviews per medical area; 11 medical areas)                                                  15 (12)
  **Type of intervention assessed**                                                                      
  Pharmacological intervention                                                                           100 (83)
  Different class \*                                                                                     72 (60)
  Same class \*                                                                                          35 (29)
  Any dose of same drug \*                                                                               12 (10)
  Non-pharmacological intervention                                                                       11 (9)
  Devices \*                                                                                             10 (8)
  Surgery or procedure \*                                                                                7 (6)
  Therapeutic strategy or education                                                                      5 (4)
  Both (pharmacological and non-pharmacological intervention)                                            10 (8)
  **Type of network**                                                                                    
  No of interventions assessed per network†                                                              7 (5-9)
  No of comparisons conducted by at least one randomised controlled trial (per network meta-analysis)†   10 (6-15)
  No of network meta-analyses with at least one closed loop                                              103 (85)
  No of randomised controlled trials included in network meta-analysis (per network meta-analysis)†      22 (15-40)

Data are no (%) of reports unless stated otherwise.

\*Multiple answers were possible, so the total does not equal 100%.

†Data are median (interquartile range).

Reporting of key methodological components of the systematic review process
---------------------------------------------------------------------------

Only three (2%) network meta-analyses did not report the databases searched in the methods section; of the remaining 118, 99 (82%) used a de novo search strategy and 19 (16%) a mixed search strategy. However, 42 (35%) did not report searching other sources, and 39 (32%) did not report any information regarding restriction or no restriction of study selection related to publication status (table 2[](#tbl2){ref-type="table"}). In addition, 42 (35%) and 32 (26%) network meta-analyses did not report the methods used for study selection and data extraction, respectively. A total of 61 (50%) network meta-analyses did not report any information regarding the assessment of risk of bias of individual studies. Of 121 network meta-analyses, 103 (85%) did not report any methods to assess the likelihood of publication bias.

###### 

 Reporting of key methodological components of the systematic review process in network meta-analyses, by journal type

  Items                                                                                                                                                                                                                     Overall (n=121)   General journals (n=55)   Specialty journals (n=66)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------- ------------------------- ---------------------------
  **Introduction**                                                                                                                                                                                                                                                      
  Questions referring to participants, interventions, comparisons, outcomes, and study design                                                                                                                               110 (91)          51 (93)                   59 (89)
  **Methods**                                                                                                                                                                                                                                                           
  Existence of systematic review protocol                                                                                                                                                                                   15 (12)           9 (16)                    6 (9)
  Primary outcome(s)                                                                                                                                                                                                        85 (70)           44 (80)                   41 (62)
  Information sources searched                                                                                                                                                                                                                                          
   Databases searched                                                                                                                                                                                                       118 (98)          53 (96)                   65 (98)
   Electronic search strategy for each database                                                                                                                                                                             33 (27)           19 (35)                   14 (21)
   Date of last search for each database                                                                                                                                                                                    109 (90)          50 (91)                   59 (89)
   Period covered by search for each database                                                                                                                                                                               83 (69)           36 (65)                   47 (71)
   Search for any other sources (conference abstracts, unpublished studies, textbooks, specialty registers, contact with study authors, reviewing the references in the studies found or any relevant systematic reviews)   79 (65)           38 (69)                   41 (62)
   Reviewing the references in the studies found or any relevant systematic reviews                                                                                                                                         54 (45)           27 (49)                   27 (41)
   Search for ongoing studies                                                                                                                                                                                               19 (16)           13 (24)                   6 (9)
   Restriction or no restriction related to language                                                                                                                                                                        92 (76)           42 (76)                   50 (76)
   Restriction or no restriction related to the publication status                                                                                                                                                          82 (68)           38 (69)                   44 (67)
  Study selection and data collection process                                                                                                                                                                                                                           
   Process for selecting studies                                                                                                                                                                                            79 (65)           35 (64)                   44 (67)
   Method of data extraction                                                                                                                                                                                                89 (74)           42 (76)                   47 (71)
  Methods used for assessing risk of bias of individual studies                                                                                                                                                             60 (50)           27 (49)                   33 (50)
  Methods to incorporate assessment of risk of bias of individual studies in the analysis or conclusions of review                                                                                                                                                      
   Subgroup analysis                                                                                                                                                                                                        9 (7)             4 (7)                     5 (8)
   Inclusion criteria                                                                                                                                                                                                       4 (3)             1 (2)                     3 (5)
   GRADE                                                                                                                                                                                                                    4 (3)             4 (7)                     0 (0)
   Adjustment                                                                                                                                                                                                               2 (2)             2 (4)                     0 (0)
   Any of these methods                                                                                                                                                                                                     19 (16)           11 (20)                   8 (13)
  Assessment of risk of bias that may affect the cumulative evidence (publication bias)                                                                                                                                     18 (15)           11(20)                    7 (11)
  **Results**                                                                                                                                                                                                                                                           
  Study selection                                                                                                                                                                                                                                                       
   No of studies screened, assessed for eligibility, and included in the review                                                                                                                                             90 (74)           43 (78)                   47 (71)
   List of studies included                                                                                                                                                                                                 117 (97)          53 (96)                   64 (97)
   List of studies excluded                                                                                                                                                                                                 9 (7)             6 (11)                    3 (5)
  Study characteristics                                                                                                                                                                                                                                                 
   Description of network                                                                                                                                                                                                   82 (68)           39 (71)                   43 (65)
   Characteristics of patients (for example, age, female:male ratio)                                                                                                                                                        70 (58)           30 (55)                   40 (61)
   Duration of follow-up of patients                                                                                                                                                                                        60 (50)           26 (47)                   34 (52)
   Duration of interventions                                                                                                                                                                                                34 (28)           15 (27)                   19 (29)
   Description of interventions                                                                                                                                                                                             64 (53)           30 (55)                   34 (52)
   No of study groups                                                                                                                                                                                                       95 (79)           42 (76)                   53 (80)
   No of patients                                                                                                                                                                                                           97 (80)           41 (75)                   56 (85)
   Funding source                                                                                                                                                                                                           13 (11)           8 (15)                    5 (8)
  Risk of bias within studies                                                                                                                                                                                               51 (42)           23 (42)                   28 (42)
  Risk of bias across studies (publication bias)                                                                                                                                                                            18 (15)           11 (20)                   7 (11)
  **Discussion**                                                                                                                                                                                                                                                        
  Reporting of limitations at review level (reporting or publication bias)                                                                                                                                                  58 (48)           32 (58)                   26 (39)
  **Other items**                                                                                                                                                                                                                                                       
  Assumptions required in network meta-analysis                                                                                                                                                                                                                         
   Homogeneity assumption                                                                                                                                                                                                   107 (88)          50 (91)                   57 (86)
   Similarity assumption                                                                                                                                                                                                    41 (34)           18 (33)                   23 (35)
   Consistency or exchangeability assumption                                                                                                                                                                                58 (48)           32 (58)                   26 (39)
  Conflict of interest                                                                                                                                                                                                      95 (79)           47 (85)                   48 (73)

Data are number (%) of reports featuring the corresponding item.

In the results section, 95 (79%) network meta-analyses did not describe the characteristics of primary studies (that is, characteristics of the network, patient characteristics, and interventions); 70 (58%) did not report the risk of bias assessment within studies.

The similarity and consistency assumptions were not frequently mentioned in network meta-analyses (66% (n=80) and 44% (n=63) of reports, respectively; table 2).These findings did not differ by journal type or funding source (web table 4).

Conduct quality when the reporting was adequate
-----------------------------------------------

For network meta-analyses with adequate reporting, the conduct quality was frequently inadequate: 11% of these network meta-analyses involved a search of only one bibliographic database, 20% restricted the study selection to published articles, 43% lacked an independent duplicate study selection, and 21% lacked an independent extraction of duplicate data. These findings did not differ by journal type or funding source (table 3[](#tbl3){ref-type="table"}; web table 5).

###### 

 Inadequate quality of conduct of the systematic review process with adequate reporting in network meta-analyses, by journal type

  Item (reported and of inadequate quality of conduct)         Overall       General journal   Specialty journal
  ------------------------------------------------------------ ------------- ----------------- -------------------
  Electronic search of only one bibliographic database         13/118 (11)   8/53 (15)         5/65 (8)
  Restriction of study selection based on publication status   16/82 (20)    6/38 (16)         10/44 (23)
  Lack of independent duplicate study selection                34/79 (43)    13/37 (35)        21/42 (50)
  Lack of independent duplicate data extraction                19/89 (21)    10/41 (24)        9/48 (19)

Data are number (%)/total number of reports. Denominators of fractions indicate the total number of reports in which the corresponding item was reported.

Composite outcome assessing inadequate reporting or inadequate conduct quality
------------------------------------------------------------------------------

Overall, 87 network meta-analyses (72%) showed inadequate reporting of key methodological components or inadequate conduct quality according to guidelines from Li and colleagues.[@ref29] This measurement did not differ by journal type (general journal, 69% (95% confidence interval 57% to 81%); specialty journal, 74% (63% to 85%); P=0.5) or funding source (public funding, 67% (74% to 79%); private funding, 79% (67% to 90%); P=0.2).

We used a second composite according to the seven mandatory items of methodological expectations of Cochrane intervention reviews.[@ref30] Based on this composite, 120 network meta-analyses (99%) showed inadequate reporting of key methodological components or inadequate conduct. These findings did not differ by journal type or funding source.

Discussion
==========

We identified 121 reports of network meta-analyses covering a wide range of medical areas. Key methodological components of the systematic review process were missing in most reports. The reporting did not differ by publication in a general or specialty journal or by public or private funding.

Several guidelines have been developed to assess the methodological quality and reporting of systematic reviews and meta-analyses,[@ref26] [@ref30] [@ref31] [@ref32] [@ref33] and according to all these guidelines, retrieving all relevant studies is crucial for the success of every systematic review. The literature search needs to be exhaustive and adequate to maximise the likelihood of capturing all relevant studies and minimise the effects of reporting biases that might influence the nature and direction of results.[@ref34] [@ref35] [@ref36] More than half of our network meta-analyses failed to report exhaustive searches; for those with adequate reporting, 11% searched only one electronic database (web table 6).

In addition, more than half of our network meta-analyses did not describe the characteristics of patients, the duration of follow-up or treatment, or the intervention. The lack of adequate reporting of the characteristics of primary studies raises several problems. Knowing precisely the type of intervention, characteristics, and duration of follow-up and treatment is a preliminary step for researchers and readers to assess the assumption of similarity required in network meta-analyses.[@ref12] [@ref37]

An important step of the systematic review process is to assess the risk of bias of individual studies.[@ref38] [@ref39] [@ref40] [@ref41] [@ref42] The risk of bias in individual studies could affect the findings of network meta-analyses.[@ref43] However, 58% of our network meta-analyses did not report the risk of bias of individual studies in the results sections, and 84% did not report a method to incorporate assessment of risk of bias of individual studies in the analysis or conclusions of the review (web table 6).

Publication bias could affect the results of meta-analyses and network meta-analyses.[@ref44] [@ref45] [@ref46] [@ref47] This factor is all the more important, considering that we lacked the validated methods to detect or to appropriately adjust or exclude reporting bias in network meta-analyses. Moreover, reporting bias across trials could differentially affect the various comparisons in the network and modify the rank order efficacy of treatments. However, most of our network meta-analyses (85%) did not report a method to assess the publication bias. Although reporting bias could have a substantial effect on the conclusions of a network meta-analysis, it is probably neglected.

Strengths and limitations of study
----------------------------------

To the best of our knowledge, no study investigated the systematic review process in network meta-analyses (mixed treatment, comparison meta-analyses).[@ref10] [@ref13] Recently, the Agency for Healthcare Research and Quality assessed the statistical methods used in a sample of published network meta-analyses, but did not analyse the conduct and reporting of the systematic review process.[@ref48]

Our study had some limitations. Assessing conduct quality from published reports alone could be unreliable, as has been shown for randomised trials.[@ref49] The study authors may have used adequate methods but omitted important details from their reports, or key information may have been deleted during the publication process. However, we were in the position of the reader, who can only assess what was reported. In addition, we judged that the conduct quality was inadequate only if the reporting was adequate. Furthermore, we did not assess health technology assessment reports, which could have had higher quality or precision than the reports analysed.

Conclusions and implications
----------------------------

Our study identified some important methodological components in the reports of network meta-analyses that may raise doubts about the confidence we could have in their conclusions. Potential flaws in the conduct of network meta-analyses could affect their findings. Performing a network meta-analysis outside the realm of a systematic review, without extensive and thorough searches for eligible trials, and without risk of bias assessments of trials, would increase the risk of a network meta-analysis producing biased results. Guidelines are needed to improve the quality of reporting and conduct of network meta-analyses.

### What is already known on this topic

1.  Network meta-analyses are primarily meta-analyses, and should be conducted by respecting the methodological rules of systematic reviews

2.  Network meta-analyses are subject to the same methodological risks of standard pairwise systematic reviews, and because this method in network meta-analyses is complex, it is probably more vulnerable to these risks

### What this study adds

1.  Key methodological components of the systematic review process are frequently inadequately reported in publications of network meta-analyses

2.  The level of inadequate reporting does not differ between reports published by a general or specialty journal or between reports with public or private funding

3.  Inadequate reporting of results of network meta-analyses raises doubts about the ability of network meta-analyses to help clinical researchers determine the best available treatment
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